結膜炎治療薬の世界市場:細菌性結膜炎、ウイルス性結膜炎、アレルギー性結膜炎...市場調査レポートについてご紹介

【英文タイトル】Global Conjunctivitis Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Overview: Conjunctivitis
• Types of conjunctivitis
• Signs and symptoms
• Diagnosis

PART 06: Pipeline analysis
• AC-170
• AGN-229666
• DEXTENZA
• SUN-1334H
• Auriclosene
• EBI-005
• FST-100
• SPL7013
• OPX-1
• AzaSite Xtra (ISV-405)
• GD134

PART 07: Market landscape
• Market overview
• Market size and forecast
• Conjunctivitis medication market in the US
• Bacterial conjunctivitis medication market in the US
• Viral conjunctivitis medication market in the US
• Allergic conjunctivitis medication market in the US
• Five forces analysis

PART 08: Market segmentation based on condition type
• Bacterial conjunctivitis medication
• Viral conjunctivitis medication
• Allergic conjunctivitis medication
• Global bacterial conjunctivitis medication market
• Global viral conjunctivitis medication market
• Global allergic conjunctivitis medication market

PART 09: Geographical segmentation
• Geographical segmentation of global conjunctivitis medication market
• Conjunctivitis medication market in the Americas
• Conjunctivitis medication market in EMEA
• Conjunctivitis medication market in APAC

PART 10: Market drivers
• Increased exposure to chemicals and pollutants
• Rising awareness of condition
• Exploring specific treatment for viral conjunctivitis
• Tentative approval of pipeline candidates

PART 11: Impact of drivers

PART 12: Market challenges
• Patent expiry of medication
• Contentment with existing therapies
• Adverse effects and limited efficacy of medication

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Strategic alliances and M&A
• Use of combination therapies
• Increased R&D

PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2014
• Other prominent vendors

PART 16: Key vendor analysis
• Akorn
• Alcon
• Allergan
• Bausch & Lomb

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Causes of conjunctivitis
Exhibit 03: Types of bacterial conjunctivitis
Exhibit 04: Types of viral conjunctivitis
Exhibit 05: Types of allergic conjunctivitis
Exhibit 06: Signs and symptoms of common forms of conjunctivitis
Exhibit 07: Medication used for treatment of conjunctivitis
Exhibit 08: Global conjunctivitis market: Pipeline portfolio
Exhibit 09: Global conjunctivitis market 2014-2019 ($ billions)
Exhibit 10: Conjunctivitis market in the US 2014-2019 ($ billions)
Exhibit 11: Percentage shares of conjunctivitis medication market in the US and outside the US
Exhibit 12: Segmentation of conjunctivitis medication market in US based on condition type 2014
Exhibit 13: Bacterial conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 14: Viral conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 15: Allergic conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 16: Conjunctivitis market in US: YoY growth and revenue based on condition type 2014-2019
Exhibit 17: Five forces analysis
Exhibit 18: Segmentation of global conjunctivitis medication market based on condition type
Exhibit 19: Segmentation of global conjunctivitis medication market based on condition type 2014
Exhibit 20: Global bacterial conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 21: Global viral conjunctivitis medication market 2014-2019 ($ millions)
Exhibit 22: Global allergic conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 23: Global conjunctivitis medication market: YoY growth and revenue based on condition type 2014-2019
Exhibit 24: Geographical segmentation of global conjunctivitis medication market 2014
Exhibit 25: Conjunctivitis medication market in the Americas 2014-2019 ($ billions)
Exhibit 26: Conjunctivitis medication market in EMEA 2014-2019 ($ millions)
Exhibit 27: Conjunctivitis medication market in APAC 2014-2019 ($ millions)
Exhibit 28: YoY growth and revenue of global conjunctivitis medication market by region 2014-2019
Exhibit 29: Impact of drivers
Exhibit 30: Impact of drivers and challenges
Exhibit 31: YoY growth and revenue generated from sales of ophthalmic therapeutics 2011-2013 ($ millions)
Exhibit 32: Akorn: Key takeaways
Exhibit 33: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions)
Exhibit 34: Percentage share of divisions of Alcon based on revenue 2014
Exhibit 35: Alcon: Key takeaways
Exhibit 36: Allergan: Key takeaways
Exhibit 37: Allergan: Business segmentation 2014 by revenue
Exhibit 38: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 39: Allergan: Geographical segmentation by revenue 2014
Exhibit 40: Bausch & Lomb: Product categories


【レポート販売概要】

■ タイトル:結膜炎治療薬の世界市場:細菌性結膜炎、ウイルス性結膜炎、アレルギー性結膜炎
■ 英文:Global Conjunctivitis Market 2015-2019
■ 発行日:2016年1月20日
■ 調査会社:Technavio
■ 商品コード:IRTNTR7542
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。